Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

NCT01266525 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia Alzheimer's Type

Interventions

DRUG: SAR110894
DRUG: placebo (for SAR110894)
DRUG: Donepezil

Sponsor

Sanofi